Cogent Biosciences, Inc. (COGT)
34.76
-0.19
(-0.54%)
USD |
NASDAQ |
Sep 04, 16:00
34.76
0.00 (0.00%)
After-Hours: 17:41
Cogent Biosciences Cash and Short Term Investments (Annual) : 900.76M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 900.76M |
| December 31, 2024 | 287.08M |
| December 31, 2023 | 265.71M |
| December 31, 2022 | 260.53M |
| December 31, 2021 | 219.68M |
| December 31, 2020 | 242.19M |
| Date | Value |
|---|---|
| December 31, 2019 | 37.42M |
| December 31, 2018 | 78.59M |
| December 31, 2017 | 41.04M |
| December 31, 2016 | 68.51M |
| December 31, 2015 | 90.48M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Apogee Therapeutics, Inc. | 730.19M |
| Erasca, Inc. | 276.08M |
| Moderna, Inc. | 5.80B |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |